Health Trials

Metastatic Lobular Breast Carcinoma

2

Review clinical trials related to Metastatic Lobular Breast Carcinoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

[68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC)

This is a prospective study using \[68Ga\]Ga DOTA-5G PET/CT imaging in patients diagnosed with metastatic/advanced invasive lobular breast cancer (LBC).

Participants needed: 30
Trial details
Phase: Phase 1Age: 18-89Biological sex: AllType: InterventionalSponsor: University of California, DavisUpdated: Mar 23, 2026Locations: 1
Eligibility criteria

(Ability to understand and willingness to sign a written informed consent docume... [+8]

Pregnant and lactating women [+3]

Read more
Status: Recruiting

A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer

The purpose of this study to compare two types of cancer imaging scans to see which is better at detecting and monitoring metastatic ILC. This study will compare PET/CT (positron emission tomography/computed tomography) scans using the radiotracer fluorine 18 (18F)-fluoroestradiol (FES) with a standard imaging approach for detecting and monitoring ILC, PET/CT scans using the radiotracer 18F-fluorodeoxyglucose (FDG). These scans will be referred to as FES PET/CT scans and FDG PET/CT scans.

Participants needed: 30
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Memorial Sloan Kettering Cancer CenterUpdated: Feb 27, 2026Locations: 7
Eligibility criteria

Adult patient > 18 years old [+6]

Low ER expression defined as ER <10% of tumor cells by IHC [+3]

Read more